What should we expect from a bioartificial liver in fulminant hepatic failure?

被引：16
|
作者：
Bismuth, H [1 ]
Figueiro, J
Samuel, D
机构：
[1] Hop Paul Brousse, Fac Med Paris Sud, Ctr Hepatobiliaire, F-94800 Villejuif, France
[2] Assistance Publ Hop Paris, Ctr Hepatobiliaire, Villejuif, France
来源：
ARTIFICIAL ORGANS | 1998年 / 22卷 / 01期
关键词：
fulminant hepatitis; liver transplantation; bioartificial liver;
D O I：
10.1046/j.1525-1594.1998.06059.x
中图分类号：
R318 [生物医学工程];
学科分类号：
0831 ;
摘要：
Fulminant hepatic failure is associated with high mortality. Liver transplantation is an effective therapy that improves survival, and because of donor organ shortage and urgency, a bioartificial liver could act as an effective bridge to liver transplantation in patients with fulminant hepatic failure. We discuss the place of the bioartificial liver in the treatment of other causes of liver failure.
引用
收藏
页码：26 / 31
页数：6
相关论文
共 50 条
  • [21] The Guidelines: What should we expect?
    Fernandez, H.
    Marret, H.
    Fritel, X.
    JOURNAL DE GYNECOLOGIE OBSTETRIQUE ET BIOLOGIE DE LA REPRODUCTION, 2012, 41 (01): : 1 - 2
  • [22] In vivo efficacy of a bioartificial liver in improving spontaneous recovery from fulminant hepatic failure:: A controlled study in pigs
    Cuervas-Mons, V
    Colás, A
    Rivera, JA
    Prados, E
    TRANSPLANTATION, 2000, 69 (03) : 337 - 344
  • [23] Bioartificial liver in the treatment of hepatic failure
    Maddrey, WC
    LIVER TRANSPLANTATION, 2000, 6 (04) : S27 - S30
  • [24] Should trials of liver xenotransplantation proceed in toxic fulminant hepatic failure?
    Horton, Peter J.
    Chaudhury, Prosanto
    Rochon, Caroline
    Metrakos, Peter
    Tchervenkov, Jean
    XENOTRANSPLANTATION, 2006, 13 (06) : 483 - 483
  • [25] Efficacy of Fluidized Bed Bioartificial Liver in Treating Fulminant Hepatic Failure in Pigs: A Metabolomics Study
    Pengcheng Zhou
    Li Shao
    Lifu Zhao
    Guoliang Lv
    Xiaoping Pan
    Anye Zhang
    Jianzhou Li
    Ning Zhou
    Deying Chen
    Lanjuan Li
    Scientific Reports, 6
  • [26] Comparative study of bioartificial liver support and plasma exchange for treatment of pigs with fulminant hepatic failure
    Kamohara, Y
    Fujioka, H
    Eguchi, S
    Kawashita, Y
    Furui, J
    Kanematsu, T
    ARTIFICIAL ORGANS, 2000, 24 (04) : 265 - 270
  • [27] Efficacy of Fluidized Bed Bioartificial Liver in Treating Fulminant Hepatic Failure in Pigs: A Metabolomics Study
    Zhou, Pengcheng
    Shao, Li
    Zhao, Lifu
    Lv, Guoliang
    Pan, Xiaoping
    Zhang, Anye
    Li, Jianzhou
    Zhou, Ning
    Chen, Deying
    Li, Lanjuan
    SCIENTIFIC REPORTS, 2016, 6
  • [28] An experimental large animal model for the assessment of bioartificial liver support systems in fulminant hepatic failure
    Ytrebo, LM
    Nedredal, GI
    Langbakk, B
    Revhaug, A
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2002, 37 (09) : 1077 - 1088
  • [29] Bioartificial liver treatment prolongs survival and lowers intracranial pressure in pigs with fulminant hepatic failure
    Khalili, TM
    Navarro, A
    Ting, P
    Kamohara, Y
    Arkadopoulos, N
    Solomon, BA
    Demetriou, AA
    Rozga, J
    ARTIFICIAL ORGANS, 2001, 25 (07) : 566 - 570
  • [30] NEUROLOGIC CHANGES IN FULMINANT HEPATIC-FAILURE (FHF) PATIENTS TREATED WITH A BIOARTIFICIAL LIVER (BAL)
    ROSEN, HR
    KONG, LB
    LEPAGE, EB
    ROZGA, J
    HOFFMAN, A
    DEMETRIOU, AA
    HEPATOLOGY, 1994, 20 (04) : A139 - A139
12345